Clinical Trials Directory

Trials / Completed

CompletedNCT01862276

Role of Bile Duct Resection in Major Hepatectomy Due to Intrahepatic Cholangiocarcinoma

Status
Completed
Phase
Study type
Observational
Enrollment
200 (actual)
Sponsor
Kansai Hepatobiliary Oncology Group · Network
Sex
All
Age
Healthy volunteers
Not accepted

Summary

To investigate the prognosis due to presence or absence of bile duct resection in intrahepatic cholangiocarcinoma that require hepatic lobectomy.

Detailed description

The bile duct resection in hepatic lobectomy due to cholangiocarcinoma, mass forming type, is still controversial. We retrospectively evaluated the effect of bile duct resection in this surgery.

Conditions

Timeline

Start date
2013-03-01
Primary completion
2014-03-01
Completion
2014-03-01
First posted
2013-05-24
Last updated
2014-07-01

Locations

1 site across 1 country: Japan

Source: ClinicalTrials.gov record NCT01862276. Inclusion in this directory is not an endorsement.

Role of Bile Duct Resection in Major Hepatectomy Due to Intrahepatic Cholangiocarcinoma (NCT01862276) · Clinical Trials Directory